메뉴 건너뛰기




Volumn 53, Issue 10, 2008, Pages 774-780

Practical issues in the management of low-risk gestational trophoblast tumors

Author keywords

Chemotherapy; Gestational trophoblastic tumor; Human chorionic gonadotropin; Molar pregnancy

Indexed keywords

CHORIONIC GONADOTROPIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; FOLINIC ACID; METHOTREXATE; VINCRISTINE;

EID: 55349149663     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (18)

References (38)
  • 1
    • 0028345241 scopus 로고
    • Advances in the epidemiology of gestational trophoblastic disease
    • Palmer JR: Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med 1994;39:155-162
    • (1994) J Reprod Med , vol.39 , pp. 155-162
    • Palmer, J.R.1
  • 2
    • 0242691792 scopus 로고    scopus 로고
    • Epidemiology and aetiology of gestational trophoblastic diseases
    • Altieri A, Franceschi S, Ferlay J, et al: Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol 2003;4:670-678
    • (2003) Lancet Oncol , vol.4 , pp. 670-678
    • Altieri, A.1    Franceschi, S.2    Ferlay, J.3
  • 3
    • 0022547902 scopus 로고
    • Hydatidiform mole in England and Wales 1973-83
    • Bagshawe KD, Dent J, Webb J: Hydatidiform mole in England and Wales 1973-83. Lancet 1986;2:673-677
    • (1986) Lancet , vol.2 , pp. 673-677
    • Bagshawe, K.D.1    Dent, J.2    Webb, J.3
  • 4
    • 0020656089 scopus 로고
    • Natural history of hydatidiform mole after primary evacuation
    • Lurain JR, Brewer JI, Torok EE, et al: Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol 1983;145:591-595
    • (1983) Am J Obstet Gynecol , vol.145 , pp. 591-595
    • Lurain, J.R.1    Brewer, J.I.2    Torok, E.E.3
  • 6
    • 0028862073 scopus 로고
    • The changing clinical presentation of complete molar pregnancy
    • Soto-Wright V, Bernstein M, Goldstein DP, et al: The changing clinical presentation of complete molar pregnancy. Obstet Gynecol 1995;86:775-779
    • (1995) Obstet Gynecol , vol.86 , pp. 775-779
    • Soto-Wright, V.1    Bernstein, M.2    Goldstein, D.P.3
  • 7
    • 0029885043 scopus 로고    scopus 로고
    • Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy
    • Roberts JP, Lurain JR: Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy. Am J Obstet Gynecol 1996;17:1917-1923
    • (1996) Am J Obstet Gynecol , vol.17 , pp. 1917-1923
    • Roberts, J.P.1    Lurain, J.R.2
  • 8
    • 0036534303 scopus 로고    scopus 로고
    • Low-risk persistent gestational trophoblastic disease: Outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000
    • McNeish IA, Strickland S, Holden L, et al: Low-risk persistent gestational trophoblastic disease: Outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 2002;20:1838-1844
    • (2002) J Clin Oncol , vol.20 , pp. 1838-1844
    • McNeish, I.A.1    Strickland, S.2    Holden, L.3
  • 9
    • 33750218149 scopus 로고    scopus 로고
    • Management of postmolar gestational trophoblastic disease with methotrexate and folinic acid: 15 years of experience
    • Sekharan PK, Sreedevi NS, Radhadevi VP, et al: Management of postmolar gestational trophoblastic disease with methotrexate and folinic acid: 15 years of experience. J Reprod Med 2006;51:835-840
    • (2006) J Reprod Med , vol.51 , pp. 835-840
    • Sekharan, P.K.1    Sreedevi, N.S.2    Radhadevi, V.P.3
  • 10
    • 0036623106 scopus 로고    scopus 로고
    • Clinical characteristics of gestational trophoblastic disease at a single institute
    • Alici S, Eralp Y, Saip P, et al: Clinical characteristics of gestational trophoblastic disease at a single institute. Tohoku J Exp Med 2002;197:95-100
    • (2002) Tohoku J Exp Med , vol.197 , pp. 95-100
    • Alici, S.1    Eralp, Y.2    Saip, P.3
  • 11
    • 33751245927 scopus 로고    scopus 로고
    • Gestational trophoblastic neoplasia: Clinical trends in 8 years at Hospital Universitario de Caracas
    • Cortés-Charry R, Figueira LM, García-Barriola V, et al: Gestational trophoblastic neoplasia: Clinical trends in 8 years at Hospital Universitario de Caracas. J Reprod Med 2006;51: 888-891
    • (2006) J Reprod Med , vol.51 , pp. 888-891
    • Cortés-Charry, R.1    Figueira, L.M.2    García-Barriola, V.3
  • 12
    • 0034041479 scopus 로고    scopus 로고
    • Review of trophoblastic disease at Taipei Veterans General Hospital
    • Wang JC, Wang PH, Yuan CC: Review of trophoblastic disease at Taipei Veterans General Hospital. Zhonghua Yi Xue Za Zhi (Taipei) 2000;63:399-406
    • (2000) Zhonghua Yi Xue Za Zhi (Taipei) , vol.63 , pp. 399-406
    • Wang, J.C.1    Wang, P.H.2    Yuan, C.C.3
  • 13
    • 0024371428 scopus 로고
    • The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT)
    • Bagshawe KD, Dent J, Newlands ES, et al: The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynaecol 1989;96:795-802
    • (1989) Br J Obstet Gynaecol , vol.96 , pp. 795-802
    • Bagshawe, K.D.1    Dent, J.2    Newlands, E.S.3
  • 14
    • 0030757259 scopus 로고    scopus 로고
    • EMA/CO for highrisk gestational trophoblastic tumors: Results from a cohort of 272 patients
    • Bower M, Newlands ES, Holden L, et al: EMA/CO for highrisk gestational trophoblastic tumors: Results from a cohort of 272 patients. J Clin Oncol 1997;15:2636-2643
    • (1997) J Clin Oncol , vol.15 , pp. 2636-2643
    • Bower, M.1    Newlands, E.S.2    Holden, L.3
  • 15
    • 0033982236 scopus 로고    scopus 로고
    • Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors
    • Newlands ES, Mulholland PJ, Holden L, et al: Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol 2000;18:854-859
    • (2000) J Clin Oncol , vol.18 , pp. 854-859
    • Newlands, E.S.1    Mulholland, P.J.2    Holden, L.3
  • 16
    • 25144505680 scopus 로고    scopus 로고
    • The curative effect of a second curettage in persistent trophoblastic disease: A retrospective cohort survey
    • Garner EI, Feltmate CM, Goldstein DP, et al: The curative effect of a second curettage in persistent trophoblastic disease: A retrospective cohort survey. Gynecol Oncol 2005;99:3-5
    • (2005) Gynecol Oncol , vol.99 , pp. 3-5
    • Garner, E.I.1    Feltmate, C.M.2    Goldstein, D.P.3
  • 17
    • 0036284589 scopus 로고    scopus 로고
    • FIGO staging for gestational trophoblastic neoplasia
    • FIGO Oncology Committee
    • FIGO Oncology Committee: FIGO staging for gestational trophoblastic neoplasia. Int J Gynaecol Obstet 2002;77:285-287
    • (2002) Int J Gynaecol Obstet , vol.77 , pp. 285-287
  • 18
    • 2942644607 scopus 로고    scopus 로고
    • Diagnosis and treatment of gestational trophoblastic disease
    • ACOG Practice Bulletin 53
    • ACOG Practice Bulletin 53: Diagnosis and treatment of gestational trophoblastic disease. Gynecol Oncol 2004;93:575-585
    • (2004) Gynecol Oncol , vol.93 , pp. 575-585
  • 19
    • 25144495095 scopus 로고    scopus 로고
    • Second curettage in persistent trophoblastic disease (FTD): The need for univocal definition of PTD
    • van Trommel NE, Thomas CM, Massuger LF, et al: Second curettage in persistent trophoblastic disease (FTD): The need for univocal definition of PTD. Gynecol Oncol 2005;99:250-251
    • (2005) Gynecol Oncol , vol.99 , pp. 250-251
    • van Trommel, N.E.1    Thomas, C.M.2    Massuger, L.F.3
  • 20
    • 9944238410 scopus 로고    scopus 로고
    • The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease
    • Pezeshki M, Hancock BW, Silcocks P, et al: The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease. Gynecol Oncol 2004;95:423-429
    • (2004) Gynecol Oncol , vol.95 , pp. 423-429
    • Pezeshki, M.1    Hancock, B.W.2    Silcocks, P.3
  • 21
    • 25144465374 scopus 로고    scopus 로고
    • The role of repeat uterine evacuation in trophoblast disease
    • Savage P, Seckl MJ: The role of repeat uterine evacuation in trophoblast disease. Gynecol Oncol 2005;99:251-252
    • (2005) Gynecol Oncol , vol.99 , pp. 251-252
    • Savage, P.1    Seckl, M.J.2
  • 24
    • 4344685950 scopus 로고    scopus 로고
    • What is the best regimen for low-risk gestational trophoblastic neoplasia? A review
    • Osborne R, Gerulath A: What is the best regimen for low-risk gestational trophoblastic neoplasia? A review. J Reprod Med 2004;49:602-616
    • (2004) J Reprod Med , vol.49 , pp. 602-616
    • Osborne, R.1    Gerulath, A.2
  • 25
    • 0002725326 scopus 로고    scopus 로고
    • Treatment of metastatic gestational trophoblastic tumors
    • Edited by BW Hancock, ES Newlands, R Berkowitz. London, Chapman & Hall
    • Lurain JR: Treatment of metastatic gestational trophoblastic tumors. In Gestational Trophoblastic Disease. Edited by BW Hancock, ES Newlands, R Berkowitz. London, Chapman & Hall, 1997, pp 199-209
    • (1997) Gestational Trophoblastic Disease , pp. 199-209
    • Lurain, J.R.1
  • 26
    • 0022560715 scopus 로고
    • Ten years'experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease
    • Berkowitz RS, Goldstein DP, Bernstein MR: Ten years'experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol 1986; 23:111-118
    • (1986) Gynecol Oncol , vol.23 , pp. 111-118
    • Berkowitz, R.S.1    Goldstein, D.P.2    Bernstein, M.R.3
  • 27
    • 13844280396 scopus 로고    scopus 로고
    • Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy
    • Matsui H, Suzuka K, Yamazawa K, et al: Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy. Gynecol Oncol 2005;96:616-620
    • (2005) Gynecol Oncol , vol.96 , pp. 616-620
    • Matsui, H.1    Suzuka, K.2    Yamazawa, K.3
  • 28
    • 0023742415 scopus 로고
    • Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia
    • Rotmensch J, Rosenshein NB, Block BS: Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia. Gynecol Oncol 1988;29:82-86
    • (1988) Gynecol Oncol , vol.29 , pp. 82-86
    • Rotmensch, J.1    Rosenshein, N.B.2    Block, B.S.3
  • 29
    • 33644843640 scopus 로고    scopus 로고
    • Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease
    • van Trommel NE, Massuger LF, Schijf CP, ten Kate-Booij MJ, Sweep FC, Thomas CM: Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease. J Clin Oncol 2006;24:452-58
    • (2006) J Clin Oncol , vol.24 , pp. 452-458
    • van Trommel, N.E.1    Massuger, L.F.2    Schijf, C.P.3    ten Kate-Booij, M.J.4    Sweep, F.C.5    Thomas, C.M.6
  • 30
    • 0017138758 scopus 로고
    • Risk and prognostic factors in trophoblastic neoplasia
    • Bagshawe KD: Risk and prognostic factors in trophoblastic neoplasia. Cancer 1976;38:1373-1385
    • (1976) Cancer , vol.38 , pp. 1373-1385
    • Bagshawe, K.D.1
  • 31
    • 0003635670 scopus 로고
    • Gestational trophoblastic disease
    • World Health Organization
    • World Health Organization: Gestational trophoblastic disease. WHO Tech Rep Ser 692, 1983
    • (1983) WHO Tech Rep Ser , vol.692
  • 32
    • 0038395984 scopus 로고    scopus 로고
    • Persistent low levels of human chorionic gonadotropin: A premalignant gestational trophoblastic disease
    • Khanlian SA, Smith HO, Cole LA: Persistent low levels of human chorionic gonadotropin: A premalignant gestational trophoblastic disease. Am J Obstet Gynecol 2003;188:1254-1259
    • (2003) Am J Obstet Gynecol , vol.188 , pp. 1254-1259
    • Khanlian, S.A.1    Smith, H.O.2    Cole, L.A.3
  • 33
    • 33745885034 scopus 로고    scopus 로고
    • Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results
    • Cole LA, Khanlian SA, Giddings A, et al: Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results. Gynecol Oncol 2006;102:165-172
    • (2006) Gynecol Oncol , vol.102 , pp. 165-172
    • Cole, L.A.1    Khanlian, S.A.2    Giddings, A.3
  • 34
    • 33847721452 scopus 로고    scopus 로고
    • A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia
    • Powles T, Savage PM, Stebbing J, et al: A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia. Br J Cancer 2007;96:732-737
    • (2007) Br J Cancer , vol.96 , pp. 732-737
    • Powles, T.1    Savage, P.M.2    Stebbing, J.3
  • 35
    • 33750491919 scopus 로고    scopus 로고
    • The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours
    • Powles T, Young A, Sanitt A, et al: The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours. Br J Cancer 2006;95:1145-1147
    • (2006) Br J Cancer , vol.95 , pp. 1145-1147
    • Powles, T.1    Young, A.2    Sanitt, A.3
  • 36
    • 0037219647 scopus 로고    scopus 로고
    • Risk of recurrent hydatidifonn mole and subsequent pregnancy outcome following complete or partial hydatidifonn molar pregnancy
    • Sebire NJ, Fisher RA, Foskett M, et al: Risk of recurrent hydatidifonn mole and subsequent pregnancy outcome following complete or partial hydatidifonn molar pregnancy. BJOG 2003;110:22-26
    • (2003) BJOG , vol.110 , pp. 22-26
    • Sebire, N.J.1    Fisher, R.A.2    Foskett, M.3
  • 37
    • 0034969313 scopus 로고    scopus 로고
    • Subsequent pregnancy outcome in patients with spontaneous resolution of HCG after evacuation of hydatidifonn mole: Comparison between complete and partial mole
    • Matsui H, Iitsuka Y, Suzuka K, et al: Subsequent pregnancy outcome in patients with spontaneous resolution of HCG after evacuation of hydatidifonn mole: Comparison between complete and partial mole. Hum Reprod 2001;16:1274-1277
    • (2001) Hum Reprod , vol.16 , pp. 1274-1277
    • Matsui, H.1    Iitsuka, Y.2    Suzuka, K.3
  • 38
    • 0031884104 scopus 로고    scopus 로고
    • Gestational trophoblastic disease: Subsequent pregnancy outcome, including repeat molar pregnancy
    • Berkowitz RS, Im SS, Bernstein MR, et al: Gestational trophoblastic disease: Subsequent pregnancy outcome, including repeat molar pregnancy. J Reprod Med 1998;43:81-86
    • (1998) J Reprod Med , vol.43 , pp. 81-86
    • Berkowitz, R.S.1    Im, S.S.2    Bernstein, M.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.